An expert discusses how ITP treatment success is monitored through maintaining safe platelet levels and symptom control, ...

Clayton Irvine, PharmD, MBA, MS, discusses strategies to address payer-driven biosimilar and prior authorization challenges through integrated digital solutions, while advocating for flexible, ...